Clinical Trial Update: Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS) [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 trial evaluating a sarpogrelate-aspirin combination for secondary prevention of cerebral infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction

Drugs mentioned

• Aspirin (Aspirin)
• Sarpogrelate (sarpogrelate)

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Cerebral Infarction | Phase 3 | Status: COMPLETED